Péterffy Árpád, Molnár Ferenc, Sipos Dávid, Maros Tamás, Kőszegi Zsolt
Általános Orvostudományi Kar, Klinikai Központ, Kardiológiai és Szívsebészeti Klinika,Debreceni EgyetemDebrecen, Móricz Zs. krt. 22., 4032.
Magyar Honvédség Egészségügyi Központ,HonvédkórházBudapest.
Orv Hetil. 2020 Mar;161(9):354-358. doi: 10.1556/650.2020.31687.
Coronary artery bypass grafting (CABG) plays an important role in the treatment of symptomatic coronary artery disease. During the fifty years since the first operation, a great amount of clinical observations confirm that the internal mammary artery (IMA) can be used for the bypass grafting by the most favorable outcome. IMA's histological structure and physiological properties make it resistant to atherosclerosis. In our article, we remember the first CABG operation in Hungary using IMA graft and we also confirm the favorable properties of IMA by the results of the 35-year follow-up, with the longest reported coronary angiography in the literature after IMA grafting. On the basis of this case, we can speculate that the prostacyclin secretion of the mammary graft can prevent the run-off tract of the left anterior descending (LAD) artery from the atherosclerotic progression. Large-scale study is warranted to compare the long-term prognosis of the run-off tract after grafting stenting of the LAD. Orv Hetil. 2020; 161(9): 354-358.
冠状动脉旁路移植术（CABG）在有症状冠状动脉疾病的治疗中发挥着重要作用。自首例手术以来的五十年间，大量临床观察证实，胸廓内动脉（IMA）可用于旁路移植，效果最为理想。IMA的组织结构和生理特性使其具有抗动脉粥样硬化能力。在我们的文章中，我们回顾了匈牙利首例使用IMA移植物的CABG手术，并且通过35年随访结果证实了IMA的良好特性，该随访是文献中报道的IMA移植术后最长的冠状动脉造影随访。基于此病例，我们可以推测，乳腺移植物的前列环素分泌可防止左前降支（LAD）动脉的流出道发生动脉粥样硬化进展。有必要进行大规模研究，以比较LAD植入支架后移植物流出道的长期预后。《匈牙利医学周报》。2020年；161(9):354 - 358。
